A blood test given to the expectant mother between weeks 15 and 18 of pregnancy to screen for an increased risk of the baby having a birth defect. High levels of MSAFP may be associated with a neural tube defect; low levels may be associated with Down syndrome. The test is used to decide whether a woman should undergo more invasive testing, such as an amniocentesis.